Metronidazole USP from Japan
Metronidazole is a synthetic nitroimidazole derivative used primarily as an antibiotic for treating anaerobic bacterial and protozoal infections. It contains an unfused imidazole ring in its structure, qualifying it under HTS 2933.29.90.00 as a heterocyclic compound with nitrogen hetero-atoms only, specifically other unfused imidazole ring compounds.
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide Certificate of Analysis (COA) confirming purity meets USP standards and imidazole structure verification
• Comply with FDA import requirements including Drug Master File registration for active pharmaceutical ingredients
• Avoid misclassification as finished dosage forms which fall under Chapter 30